Independent Portfolio Consultants’s Boston Scientific BSX Stock Holding History

Independent Portfolio Consultants’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$161K	Sell	5,805 -2,490	-30%	-$66.1K	0.07%	328
2017 Q1	$206K	Sell	8,295 -6,185	-43%	-$150K	0.07%	327
2016 Q4	$313K	Buy	14,480 +5,975	+70%	+$130K	0.1%	259
2016 Q3	$202K	Sell	8,505 -1,445	-15%	-$34.5K	0.06%	322
2016 Q2	$233K	Sell	9,950 -9,350	-48%	-$202K	0.07%	301
2016 Q1	$363K	Sell	19,300 -500	-3%	-$8.78K	0.1%	259
2015 Q4	$365K	Sell	19,800 -1,740	-8%	-$31.2K	0.11%	247
2015 Q3	$353K	Buy	21,540 +2,875	+15%	+$49.1K	0.08%	288
2015 Q2	$330K	Buy	18,665 +3,961	+27%	+$70.8K	0.07%	305
2015 Q1	$261K	Buy	+14,704	New	+$232K	0.05%	315

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Independent Portfolio Consultants's BSX Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Boston Scientific (BSX) stake by 30% in Q2 2017, selling an estimated $66.1K and leaving 5,805 shares worth $161K. The position accounts for 0.07% of the portfolio, ranked #328.

Independent Portfolio Consultants first reported a position in BSX in Q1 2015 and has held it in 10 quarters since. The position peaked at $365K in Q4 2015. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

Independent Portfolio Consultants held 5,805 shares of Boston Scientific worth $161K as of Q2 2017.
Independent Portfolio Consultants sold 2,490 Boston Scientific shares in Q2 2017, an estimated $66.1K.
Boston Scientific made up 0.07% of Independent Portfolio Consultants's portfolio in Q2 2017, its #328 holding.
Independent Portfolio Consultants first reported a position in Boston Scientific in Q1 2015 and has held it in 10 quarters since.
Independent Portfolio Consultants's Boston Scientific position peaked at $365K in Q4 2015.
558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.